1 |
Wada K, Tazawa H, Komo T, Hadano N, Onoe T, Sudo T, Shimizu Y, Kuraoka K, Suzuki T, Tashiro H. Gastric adenocarcinoma appearance in leiomyoma: A case report. Int J Surg Case Rep 2020;71:327-30. [PMID: 32492645 DOI: 10.1016/j.ijscr.2020.05.050] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
2 |
Liu L, Han L, Ma Q, Zhang J. Gastric adenocarcinoma of fundic gland (chief cell predominant type) coexisting with well differentiated intestinal adenocarcinoma: A case report. Medicine (Baltimore) 2021;100:e25861. [PMID: 34032698 DOI: 10.1097/MD.0000000000025861] [Reference Citation Analysis]
|
3 |
Meng X, Yang G, Dong C, Zheng R. Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis. Rare Tumors 2021;13:203636132110601. [DOI: 10.1177/20363613211060171] [Reference Citation Analysis]
|
4 |
Wang D, Wang J, Song J, Shen Q, Wang R, Lu W, Pan J, Xie C, Liu M. Guanidyl and imidazolyl integration group-modified PAMAM for gastric adenocarcinoma gene therapy. J Gene Med 2020;22:e3240. [PMID: 32558063 DOI: 10.1002/jgm.3240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|